Clinical Trials in Detroit

Showing 17621-17640 of 19,719 trials

Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia

NCT00005579

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of dolastatin 10 in treating patients with indolent lymphoma, Waldenstrom's macroglobulinemia, or chronic lymphocytic leukemia.

LeukemiaLymphoma

University of VermontStarted Jun 1998

Baltimore, Maryland, United States • Detroit, Michigan, United States • Columbus, Ohio, United States +1 more locations

COMPLETEDPhase 2< 1 mile

Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer

NCT00016939

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of flavopiridol in treating patients who have unresectable or metastatic kidney cancer.

Kidney Cancer

SWOG Cancer Research NetworkStarted May 2001

Birmingham, Alabama, United States • Mobile, Alabama, United States • Phoenix, Arizona, United States +98 more locations

Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia

Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer

Find Trials by Condition in Detroit

BMS-247550 in Treating Patients With Advanced Pancreatic Cancer

EMD 121974 in Treating Patients With Progressive or Recurrent Glioma

Immunotoxin Therapy in Treating Patients With Malignant Glioma

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer

Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer

Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma

Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Irinotecan in Treating Patients With Recurrent Malignant Glioma

Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer

National Inferior Vena Cava (IVC) Filter Registry

Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma

Oral Glutamine in the Prevention of Oxaliplatin-induced Neurotoxicity

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione

A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix